arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Omada Health, Inc.

OMDA
$23.67 ▲ +3.34 (+16.43%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
11 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
39
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

Omada Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.4B
Dividend Yield
Revenue Growth 42.0%
Op. Margin -6.1%
ROIC -2.0%
FCF / Share $-0.20
Trailing P/E
Price / Book 6.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$78.05M
↑ +42.0%
Net Income Profit after all expenses
$-2.97M
↑ +68.6%
Operating Margin Operating profit as % of sales
-6.1%
↓ -241.6% 20th
FCF / Share Free cash flow per share
$-0.20
↑ +89.9%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
38
Financial Health
67
Cash Quality
9

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters